首页> 外国专利> DELAYED-RELEASE GLUCOCORTICOID TREATMENT OF RHEUMATOID ARTHRITIS BY IMPROVING SIGNS AND SYMPTOMS, SHOWING MAJOR OR COMPLETE CLINICAL RESPONSE AND BY PREVENTING FROM JOINT DAMAGE

DELAYED-RELEASE GLUCOCORTICOID TREATMENT OF RHEUMATOID ARTHRITIS BY IMPROVING SIGNS AND SYMPTOMS, SHOWING MAJOR OR COMPLETE CLINICAL RESPONSE AND BY PREVENTING FROM JOINT DAMAGE

机译:改善体征和症状,表现出重大或完全的临床反应以及预防关节损伤,以延迟释放糖皮质激素治疗类风湿关节炎

摘要

The present invention refers to the treatment of a patient suffering from rheumatoid arthritis by showing a reduction in signs and symptoms, a major or complete clinical response (remission) or even prevention of structural damages to the joints by administering a delayed-release dosage form of a glucocorticoid to a subject in need thereof.
机译:本发明涉及通过显示缓和剂型显示出症状和体征的减轻,主要或完全的临床反应(缓解)或什至防止关节的结构损伤来治疗类风湿性关节炎的患者。糖皮质激素给予需要其的受试者。

著录项

  • 公开/公告号US2013190279A1

    专利类型

  • 公开/公告日2013-07-25

    原文格式PDF

  • 申请/专利权人 HORIZON PHARMA AG;

    申请/专利号US201313791816

  • 发明设计人 ACHIM SCHÄFFLER;

    申请日2013-03-08

  • 分类号A61K31/573;

  • 国家 US

  • 入库时间 2022-08-21 16:50:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号